Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.55 is 33% above its 5-year average of -5.28, near the high end of its 5-year range (-9.43–-2.65).
14.66% above its 12-month average of -4.16.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.08.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 21 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:25:59.381Z. Historical observations retain their original dates. Historical series through 2022-11-07.
EARNINGS PER SHARE (EPS)
-3.55
EARNINGS PER SHARE (EPS) AVG TTM
-4.16
EARNINGS PER SHARE (EPS) AVG 3Y
-5.92
EARNINGS PER SHARE (EPS) AVG 5Y
-5.28
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+14.66%
CURRENT VS 3Y AVG
+40.00%
CURRENT VS 5Y AVG
+32.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Clene Inc.
Market Cap
$49.96M
Earnings Per Share (EPS)
-3.55
TTM Avg
-4.16
3Y Avg
-5.92
5Y Avg
-5.28
Market Cap
$50.25M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.36
3Y Avg
-1.71
5Y Avg
-1.31
Market Cap
$49.50M
Earnings Per Share (EPS)
-2.83
TTM Avg
-3.12
3Y Avg
-4.06
5Y Avg
-22.86
Market Cap
$50.51M
Earnings Per Share (EPS)
N/A
TTM Avg
-30.18
3Y Avg
-88.49
5Y Avg
-66.35
Market Cap
$51.12M
Earnings Per Share (EPS)
-8.95
TTM Avg
-8.42
3Y Avg
-12.89
5Y Avg
-25.33
Market Cap
$51.23M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
-0.48
Market Cap
$51.58M
Earnings Per Share (EPS)
-0.69
TTM Avg
-1.98
3Y Avg
-1.79
5Y Avg
-1.67
Market Cap
$52.95M
Earnings Per Share (EPS)
N/A
TTM Avg
-7.29
3Y Avg
-67.66
5Y Avg
-178.24
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clene Inc. (CLNN) | $49.96M | -3.55 | -4.16 | -5.92 | -5.28 |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | -0.67 | -1.36 | -1.71 | -1.31 |
| Celularity Inc. (CELU)vs › | $49.50M | -2.83 | -3.12 | -4.06 | -22.86 |
| Apollomics, Inc. (APLM)vs › | $50.51M | N/A | -30.18 | -88.49 | -66.35 |
| biote Corp. (BTMD)vs › | $49.40M | 0.12 | 0.48 | 0.24 | 1.52 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | -8.95 | -8.42 | -12.89 | -25.33 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -1.20 | -0.91 | -0.56 | -0.48 |
| INmune Bio, Inc. (INMB)vs › | $51.58M | -0.69 | -1.98 | -1.79 | -1.67 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.95M | N/A | -7.29 | -67.66 | -178.24 |
| ImageneBio Inc (IMA)vs › | $53.01M | -5.21 | -25.08 | -23.14 | -19.79 |
Trailing EPS (TTM)
$-3.55
Forward EPS (Est.)
$-1.08
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.65 |
| 2024-12-31 | -5.67 |
| 2023-12-31 | -9.43 |
| 2021-12-31 | -3.16 |
| 2020-12-31 | -5.51 |
| 2019-12-31 | -4.69 |
| 2018-12-31 | -0.09 |
| 2017-12-31 | 0.00 |
